InVivo Therapeutics Holdings Corp. Stock
Equities
NVIV.Q
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.369 USD | -1.13% | -0.27% | -49.45% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1 day | -1.13% | ||
1 week | -0.27% | ||
Current month | +67.73% | ||
1 month | +41.92% | ||
3 months | -48.97% | ||
6 months | -63.92% | ||
Current year | -49.45% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.369 | -1.13% | 13,717 |
24-04-17 | 0.3732 | +0.87% | 18,243 |
24-04-16 | 0.37 | 0.00% | 3,301 |
24-04-15 | 0.37 | 0.00% | 10,626 |
24-04-12 | 0.37 | 0.00% | 6,217 |
Delayed Quote OTC Markets, April 18, 2024 at 02:17 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-49.45% | 1.16M | |
+2.02% | 209B | |
+2.17% | 177B | |
+10.45% | 133B | |
+16.62% | 99.89B | |
-2.70% | 61.83B | |
+13.38% | 52.51B | |
-6.33% | 45.54B | |
-4.74% | 39.43B | |
+9.89% | 38.87B |
- Stock Market
- Equities
- NVIV.Q Stock